Erythropoietin Market is anticipated to reach Erythropoietin Market 2020

Erythropoietin Market is anticipated to reach
an approximate value of US$ 7 Billion by
2020: Radiant Insights, Inc
“As per RNCOS report "EPO Biosimilars - The Future
of Erythropoietin Market", the global erythropoietin
market is anticipated to reach an approximate value
of US$ 7 Billion by 2020.”
Erythropoietin is a hormone produced by healthy kidneys. This hormone prompts the bone marrow
to make the red blood cells, which then carry oxygen throughout the body. Erythropoietin is used
to treat anemia resulting from kidney failure or cancer treatment. It is considered to be an
alternative to blood transfusions. Over the last few years, the global erythropoietin industry has
been showing a sluggish growth due to patent expiry of biologic drugs. However, the biosimilar
versions of these drugs are expected to witness precipitous growth owing to their low cost.
As per RNCOS report "EPO Biosimilars - The Future of Erythropoietin Market", the global
erythropoietin market is anticipated to reach an approximate value of US$ 7 Billion by 2020. This
report provides a detailed analysis of the current and future market scenario of the global
erythropoietin market. The report highlights biosimilar erythropoietin at various stages of clinical
development. In addition, the report provides insight about the major drivers and challenges, along
with the latest trends and developments impacting the industry growth.
Browse Full Report With TOC @ http://www.radiantinsights.com/research/epo-
biosimilars-the-future-of-erythropoietin-market
Follow Us: